日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Oncolytic virus M1 reinvigorates CD8(+) T-cell immunity against glioblastoma through B-cell-dependent antigen cross-presentation in the spleen.

溶瘤病毒 M1 通过脾脏中 B 细胞依赖性抗原交叉呈递,重新激活 CD8(+) T 细胞对胶质母细胞瘤的免疫力。

Han Yu, Guo Cui, Chen Chaoxin, Yang Wenzhuo, Li Honghui, He Changjia, Deng Jialin, Chen Zhijie, Liu Wenfeng, Chen Jiehong, Zhong Yingqian, Yan Caixin, Xu Cuiying, Liang Xuanming, Zhong Sheng, Chen Furong, Li Depei, Li Cong, Hu Wanming, Chen Zhenghe, Mou Yonggao, Chen Zhongping, Yan Guangmei, Lim Michael, Zhu Wenbo, Sai Ke

The BRAF V600E/MEK/ERK/METTL3 positive feedback loop regulates autophagy and promotes stemness and invasiveness in glioblastoma via m(6)A modification.

BRAF V600E/MEK/ERK/METTL3 正反馈环通过 m(6)A 修饰调节自噬,促进胶质母细胞瘤的干性和侵袭性。

Xie Yuan, Li Yan, Tang Meiqin, Li Zhi, Hu Wanming, Qiu Xiaoling, Wang Changyu, Zou Yunzhi, Lu Jie, Yuan Ze, Chen Furong, Yang Yuanzhong, Lu Chen, Sai Ke, Guo Ying, He Zhenqiang, Duan Hao, Mou Yonggao

Genomic landscape and immunological profile of glioblastoma in East Asian patients.

东亚胶质母细胞瘤患者的基因组图谱和免疫学特征

Zhong Sheng, Wu Bo, Dubois Frank, Deng Davy, Bergholz Johann S, Hu Wanming, Duan Hao, Shao Yujie, Liu Jingyi, Liu Luwei, Chen Sitong, Hu Yongfei, Zhao Zheng, Yao Maojin, Sai Ke, Wang Jian, Chen Yinsheng, Ke Chao, Zhang Xiangheng, Yang Qunying, Guo Chengcheng, Zhang Ji, Lin Fuhua, Chen Zhenghe, Li Deipei, He Zhenqiang, Li Chang, Jiang Xiaobing, Lu Jie, Yang Wenzhuo, Jiang Tao, Chen Zhongping, Beroukhim Rameen, Zhao Jean J, Mou Yonggao

Management and survival trends for diffuse gliomas diagnosed at a single neurooncology center in China during 2000 to 2020

2000年至2020年中国某神经肿瘤中心诊断的弥漫性胶质瘤的治疗和生存趋势

Li, Depei; Chen, Yinsheng; Wong, Tang-Fai; Yang, Qunying; Guo, ChengCheng; Jiang, Xiaobing; Ke, Chao; Zhang, Xiangheng; Zeng, Jing; Lv, Yanchun; Wu, Shaoxiong; Wang, Jian; Sai, Ke; Mou, Yonggao; Chen, Zhongping

VAL-083 is effective in patients with newly-diagnosed MGMT-unmethylated glioblastoma: report of phase II study

VAL-083 对新诊断的 MGMT 未甲基化胶质母细胞瘤患者有效:II 期研究报告

Guo, Chengcheng; Yang, Qunying; Deng, Meiling; Qiu, Xiaoling; Wu, Shaoxiong; Du, Xiaojing; Sai, Ke; Dai, Ziyu; Chen, Zhenghe; Zhang, Ji; Lin, Fuhua; Ke, Chao; Xi, Shaoyan; Hu, Wanming; Zhou, Zhihuan; Li, Jiawei; Cao, Xi; Liao, Yixiang; Lv, Yanchun; Brown, Dennis; Langlands, John; Johnson, Gregory; Bacha, Jeffrey; Kwan, Claire; Kanekal, Sarath; Schwartz, Richard; Chen, Zhongping

Erratum: IL-6 derived from therapy-induced senescence facilitates the glycolytic phenotype in glioblastoma cells

更正:治疗诱导衰老产生的IL-6促进胶质母细胞瘤细胞的糖酵解表型。

Gu, Jiayu; Wang, Jingyi; Liu, Xincheng; Sai, Ke; Mai, Jialuo; Xing, Fan; Chen, Zhijie; Yang, Xiaozhi; Lu, Wanjun; Guo, Cui; Liu, Wenfeng; Xu, Yang; Xie, Shouxia; Hu, Cheng; Yan, Guangmei; Zhu, Wenbo

m6A regulator-based molecular classification and hub genes associated with immune infiltration characteristics and clinical outcomes in diffuse gliomas.

基于 m6A 调节因子的分子分型和与弥漫性胶质瘤免疫浸润特征和临床结果相关的枢纽基因

Lu Jie, Chen Siyu, Hu Wanming, Sai Ke, Li Depei, Jiang Pingping

Association between psychiatric disorders and glioma risk: evidence from Mendelian randomization analysis

精神疾病与胶质瘤风险之间的关联:来自孟德尔随机化分析的证据

Yang, Wenzhuo; Han, Yu; He, Changjia; Zhong, Sheng; Ren, Fei; Chen, Zhongping; Mou, Yonggao; Sai, Ke

Long-term survival after local immunotherapy for malignant gliomas: a retrospective study with 20 years follow-up.

恶性胶质瘤局部免疫治疗后的长期生存率:一项回顾性研究,随访时间长达 20 年

Duan Hao, He Zhenqiang, Chen Zhenghe, Chen Yukun, Hu Wanming, Sai Ke, Zhang Xiangheng, Xia Jianchuan, Li Yongqiang, Liu Ranyi, Zou Chaowei, Chen Zhongping, Mou Yonggao

Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas: A Randomized Clinical Trial

替莫唑胺辅助化疗联合或不联合干扰素α治疗新诊断的高级别胶质瘤患者:一项随机临床试验

Guo, Chengcheng; Yang, Qunying; Xu, Pengfei; Deng, Meiling; Jiang, Taipeng; Cai, Linbo; Li, Jibin; Sai, Ke; Xi, Shaoyan; Ouyang, Hui; Liu, Mingfa; Li, Xianming; Li, Zihuang; Ni, Xiangrong; Cao, Xi; Li, Cong; Wu, Shaoxiong; Du, Xiaojing; Su, Jun; Xue, Xiaoying; Wang, Yiming; Li, Gang; Qin, Zhiyong; Yang, Hui; Zhou, Tao; Liu, Jinquan; Hu, Xuefeng; Wang, Jian; Jiang, Xiaobing; Lin, Fuhua; Zhang, Xiangheng; Ke, Chao; Lv, Xiaofei; Lv, Yanchun; Hu, Wanming; Zeng, Jing; Chen, Zhenghe; Zhong, Sheng; Wang, Hairong; Chen, Yinsheng; Zhang, Ji; Li, Depei; Mou, Yonggao; Chen, Zhongping